Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis-Reference-Cited by-同舟云学术

Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis

Published:2020-01-28 Issue:3 Volume:72 Page:465-476
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Nihtyanova Svetlana I.¹^ORCID,Sari Alper²,Harvey Jennifer C.¹,Leslie Anna¹,Derrett‐Smith Emma C.¹,Fonseca Carmen¹,Ong Voon H.¹,Denton Christopher P.¹^ORCID

Affiliation:

1. UCL Division of MedicineRoyal Free Hospital London UK

2. UCL Division of MedicineRoyal Free Hospital, London, UK, and Hacettepe Üniversitesi Ankara Turkey

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41153

Reference37 articles.

1. Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting

2. An update on autoantibodies in scleroderma

3. Autoantibodies as predictive tools in systemic sclerosis

4. Anti‐fibrillarin antibodies in systemic sclerosis

5. Anti-U3 RNP autoantibodies in systemic sclerosis

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2024 British Society for Rheumatology guideline for management of systemic sclerosis;Rheumatology;2024-09-11

2. Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases;Nature Reviews Rheumatology;2024-09-02

3. Connective Tissue Disease Associated Interstitial Lung Disease;Rheumatic Disease Clinics of North America;2024-08

4. Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis;Current Opinion in Rheumatology;2024-07-25

5. Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling;Journal of Autoimmunity;2024-07